MUC16 and ovarian carcinoma: Nakae et al. demonstrated that among 32 patients with ovarian cancer, 34 patients with benign ovarian tumors, and 31 healthy women, CA125 had a sensitivity of 84.4% and a specificity of 66.3% in predicting this disease [13].